AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, J. D
Right arrow Articles by Thompson, L. U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, J. D
Right arrow Articles by Thompson, L. U
Agricola
Right arrow Articles by Brooks, J. D
Right arrow Articles by Thompson, L. U
American Journal of Clinical Nutrition, Vol. 79, No. 2, 318-325, February 2004
© 2004 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATIONS

Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy1,2,3

Jennifer D Brooks, Wendy E Ward, Jacqueline E Lewis, John Hilditch, Leslie Nickell, Evelyn Wong and Lilian U Thompson

1 From the Department of Nutritional Sciences, University of Toronto (JDB, WEW, and LUT), and the Sunnybrook Health Sciences Centre, Toronto (JEL, JH, LN, and EW)

Background: Phytoestrogens, which are abundant in flaxseed and soy, have chemical structures resembling those of endogenous estrogens and have been shown to exert hormonal effects, thereby affecting chronic diseases.

Objective: We compared the effects of consuming equal amounts of flaxseed or soy on estrogen metabolism and biochemical markers of bone metabolism in postmenopausal women.

Design: In a parallel design, the diet of postmenopausal women (n = 46) was supplemented with either a placebo, soy (25 g soy flour), or flaxseed (25 g ground flaxseed) muffin for 16 wk. Blood and 24-h urine samples were collected at baseline and at the endpoint. Urine samples were analyzed for phytoestrogens, estrogen metabolites (2-hydroxyestrone, 16{alpha}-hydroxyestrone), and serum hormones (estradiol, estrone, estrone sulfate). Serum and urine samples were also analyzed for biochemical markers of bone metabolism.

Results: Urinary concentrations of 2-hydroxyestrone, but not of 16{alpha}-hydroxyestrone, increased significantly in the flaxseed group (P = 0.05). In the flaxseed group, the ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone was positively correlated with urinary lignan excretion (r = 0.579, P = 0.02). In the soy and placebo groups, no significant correlation was observed. No significant change in serum hormones or biochemical markers of bone metabolism was observed within or between the treatment groups.

Conclusions: Supplementation with flaxseed modifies urinary estrogen metabolite excretion to a greater extent than does supplementation with an equal amount of soy. This modification by flaxseed is associated with an increase in urinary lignan excretion. Despite the shift in estrogen metabolism to favor the less biologically active estrogens, a negative effect on bone cell metabolism was not observed.

Key Words: Flaxseed lignans • soy isoflavones • estrogen metabolism • 2-hydroxyestrone • 16{alpha}-hydroxyestrone • biochemical markers of bone metabolism • postmenopausal women




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. J. Fuhrman, R. Pfeiffer, X. Xu, A. H. Wu, L. Korde, M. H. Gail, L. K. Keefer, T. D. Veenstra, R. N. Hoover, and R. G. Ziegler
Soy Intake is Associated with Increased 2-Hydroxylation and Decreased 16{alpha}-Hydroxylation of Estrogens in Asian-American Women
Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2751 - 2760.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Hooper, J.J. Ryder, M.S. Kurzer, J.W. Lampe, M.J. Messina, W.R. Phipps, and A. Cassidy
Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis
Hum. Reprod. Update, July 1, 2009; 15(4): 423 - 440.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. T. Falk, X. Xu, L. Keefer, T. D. Veenstra, and R. G. Ziegler
A Liquid Chromatography-Mass Spectrometry Method for the Simultaneous Measurement of 15 Urinary Estrogens and Estrogen Metabolites: Assay Reproducibility and Interindividual Variability
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3411 - 3418.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. M. Hamilton-Reeves, S. A. Rebello, W. Thomas, J. W. Slaton, and M. S. Kurzer
Soy Protein Isolate Increases Urinary Estrogens and the Ratio of 2:16{alpha}-Hydroxyestrone in Men at High Risk of Prostate Cancer
J. Nutr., October 1, 2007; 137(10): 2258 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-L. Low, A. M. Dunning, M. Dowsett, E. Folkerd, D. Doody, J. Taylor, A. Bhaniani, R. Luben, K.-T. Khaw, N. J. Wareham, et al.
Phytoestrogen Exposure Is Associated with Circulating Sex Hormone Levels in Postmenopausal Women and Interact with ESR1 and NR1I2 Gene Variants
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. E. McCann, J. Wactawski-Wende, K. Kufel, J. Olson, B. Ovando, S. N. Kadlubar, W. Davis, L. Carter, P. Muti, P. G. Shields, et al.
Changes in 2-Hydroxyestrone and 16{alpha}-Hydroxyestrone Metabolism with Flaxseed Consumption: Modification by COMT and CYP1B1 Genotype
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. R. French, L. U. Thompson, and G. A. Hawker
Validation of a Phytoestrogen Food Frequency Questionnaire with Urinary Concentrations of Isoflavones and Lignan Metabolites in Premenopausal Women
J. Am. Coll. Nutr., February 1, 2007; 26(1): 76 - 82.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Bergman Jungestrom, L. U. Thompson, and C. Dabrosin
Flaxseed and Its Lignans Inhibit Estradiol-Induced Growth, Angiogenesis, and Secretion of Vascular Endothelial Growth Factor in Human Breast Cancer Xenografts In vivo
Clin. Cancer Res., February 1, 2007; 13(3): 1061 - 1067.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W.-H. Wu, Y.-P. Kang, N.-H. Wang, H.-J. Jou, and T.-A. Wang
Sesame Ingestion Affects Sex Hormones, Antioxidant Status, and Blood Lipids in Postmenopausal Women
J. Nutr., May 1, 2006; 136(5): 1270 - 1275.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. Clavel, G. Henderson, C.-A. Alpert, C. Philippe, L. Rigottier-Gois, J. Dore, and M. Blaut
Intestinal Bacterial Communities That Produce Active Estrogen-Like Compounds Enterodiol and Enterolactone in Humans
Appl. Envir. Microbiol., October 1, 2005; 71(10): 6077 - 6085.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. Uzick
Naturopathic Approaches
Integr Cancer Ther, September 1, 2005; 4(3): 253 - 258.
[PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Stuedal, I. T. Gram, Y. Bremnes, H. Adlercreutz, M. B. Veierod, and G. Ursin
Plasma Levels of Enterolactone and Percentage Mammographic Density among Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2154 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. U. Thompson, J. M. Chen, T. Li, K. Strasser-Weippl, and P. E. Goss
Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer
Clin. Cancer Res., May 15, 2005; 11(10): 3828 - 3835.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Wylie-Rosett
Menopause, micronutrients, and hormone therapy
Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1223S - 1231S.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Dodin, A. Lemay, H. Jacques, F. Legare, J.-C. Forest, and B. Masse
The Effects of Flaxseed Dietary Supplement on Lipid Profile, Bone Mineral Density, and Symptoms in Menopausal Women: A Randomized, Double-Blind, Wheat Germ Placebo-Controlled Clinical Trial
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer
The Effect of Soy Consumption on the Urinary 2:16-Hydroxyestrone Ratio in Postmenopausal Women Depends on Equol Production Status but Is Not Influenced by Probiotic Consumption
J. Nutr., March 1, 2005; 135(3): 603 - 608.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Chen, E. Hui, T. Ip, and L. U. Thompson
Dietary Flaxseed Enhances the Inhibitory Effect of Tamoxifen on the Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) in Nude Mice
Clin. Cancer Res., November 15, 2004; 10(22): 7703 - 7711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society for Nutrition